CDT Equity Inc. (CDT): Share Repurchases

Annual figures by period end, from SEC filings.

$106.0K

Year ended 2025-12-31

Period ended	Share Repurchases	Change YoY	Source filing
2025-12-31	$106.0K	n/a	2026-04-15, From 2025-01-01

Share Repurchases at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Share Repurchases	Change YoY
CDT Equity Inc. (CDT)	2025-12-31	$106.0K	n/a
Earth Science Tech, Inc. (ETST)	2026-03-31	$471.4K	-67.8%
Anixa Biosciences Inc (ANIX)	2024-10-31	$6.0K	n/a
Allarity Therapeutics, Inc. (ALLR)	2025-12-31	$3.19M	n/a
Lftd Partners Inc. (LIFD)	2025-12-31	$0	-100.0%
Semnur Pharmaceuticals, Inc. (SMNR)	2024-12-31	$43.43M	+7.1%
Aspire Biopharma Holdings, Inc. (ASBP)	2024-12-31	$13.78M	-95.2%
Sunshine Biopharma Inc. (SBFM)	2025-12-31	$0	-100.0%
Atossa Therapeutics, Inc. (ATOS)	2024-12-31	$0	-100.0%

Compare CDT, ETST, ANIX, ALLR side by side · Screen every company in Pharmaceutical Preparations ↗